VTGN
NSCVistagen Therapeutics Inc.
Healthcare•Biotechnology
Watchlists:
Last updated: Wednesday 16th July 2025
2.25
-0.13 (-5.46%)
Prev Close:2.38
Open:2.38
Bid:2.27
Ask:2.43
52 Week Range
1.904.01
Volume:191,521
Mkt Cap:66 M
46
MarketXLS Rank ®
Hold
Price Target
$2.59
+15.1%
Financials
Financial Statements
VTGN - Balance Sheet (Annual)
| Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 653000.0 | 2 M | 2 M | 3 M | 838300.0 | 2 M | 1 M | 1 M | 867300.0 | 936000.0 |
| Accrued Expenses | 9 M | 4 M | 3 M | 4 M | 2 M | 2 M | 3 M | 1 M | 1 M | 2 M |
| Accumulated Depreciation & Depletion | -1 M | -1 M | -1 M | -1 M | -1 M | -1 M | -933400.0 | -842100.0 | -761400.0 | -711000.0 |
| Additional Paid In Capital | 482 M | 474 M | 343 M | 336 M | 316 M | 200 M | 192 M | 167 M | 147 M | 133 M |
| Cash And Equivalents | 67 M | 119 M | 17 M | 68 M | 103 M | 1 M | 13 M | 10 M | 3 M | 428500.0 |
| Cash Cash Equivalents And Short Term Investments | 80 M | 119 M | 17 M | 68 M | 103 M | 1 M | 13 M | 10 M | 3 M | 428500.0 |
| Common Par | 29000.0 | 27000.0 | 7000.0 | 6900.0 | 181300.0 | 49800.0 | 43300.0 | 23600.0 | 9500.0 | 3100.0 |
| Common Stock Equity | 70 M | 114 M | 12 M | 65 M | 92 M | 500.0 | 500.0 | 7 M | 615800.0 | -3 M |
| Common Stock | 29000.0 | 27000.0 | 7000.0 | 6900.0 | 180800.0 | 49300.0 | 42800.0 | 23100.0 | 9000.0 | 2600.0 |
| Current Accrued Expenses | 9 M | 2 M | 796000.0 | 1 M | 2 M | 561500.0 | 2 M | 206300.0 | 443000.0 | 814000.0 |
| Current Capital Lease Obligation | 561000.0 | 550000.0 | 486000.0 | 433300.0 | 367800.0 | 316700.0 | 3000.0 | 2600.0 | 2400.0 | 1100.0 |
| Current Deferred Assets | 74000.0 | 67000.0 | 116900.0 | 133500.0 | 355100.0 | 22300.0 | ||||
| Current Deferred Revenue | 3 M | 791000.0 | 714000.0 | 1 M | 1 M | |||||
| Current Deferred Taxes Assets | 643000.0 | |||||||||
| Current Deferred Taxes Liabilities | -5000.0 | |||||||||
| Deferred Revenues | 3 M | 791000.0 | 714000.0 | 1 M | 1 M | |||||
| Deferred Costs | 130000.0 | 218000.0 | 146400.0 | 234100.0 | ||||||
| Float Term Debt | 948000.0 | 2 M | 2 M | 3 M | 3 M | 4 M | 6300.0 | 16 M | ||
| Gross Fixed Assets (plant Property & Equipment) | 3 M | 4 M | 4 M | 4 M | 5 M | 5 M | 1 M | 1 M | 1 M | 798600.0 |
| Interest Payable | 26200.0 | 19900.0 | 1600.0 | 30100.0 | 1000.0 | 8900.0 | 770800.0 | |||
| Invested Capital | 71 M | 116 M | 14 M | 67 M | 95 M | 4 M | 6800.0 | 7 M | 615800.0 | 13 M |
| Leases | 14700.0 | 14700.0 | ||||||||
| Long Term Capital Lease Obligation | 948000.0 | 2 M | 2 M | 3 M | 3 M | 4 M | 6300.0 | 9300.0 | 11900.0 | |
| Long Term Debt And Capital Lease Obligation | 948000.0 | 2 M | 2 M | 3 M | 3 M | 4 M | 6300.0 | 9300.0 | 11900.0 | 27200.0 |
| Net Fixed Assets (net PP&E) | 2 M | 2 M | 3 M | 3 M | 4 M | 4 M | 312700.0 | 207400.0 | 286500.0 | 87600.0 |
| Non-current Deferred Income Taxes | -5000.0 | |||||||||
| Non Current Deferred Assets | 130000.0 | 218000.0 | 146400.0 | 234100.0 | ||||||
| Non Current Deferred Liabilities | 391000.0 | 3 M | 2 M | 2 M | 2 M | 381100.0 | 285600.0 | 139200.0 | 55500.0 | |
| Non Current Deferred Revenue | 391000.0 | 3 M | 2 M | 2 M | 2 M | 381100.0 | ||||
| Non Current Deferred Taxes Assets | 59 M | -49 M | -40 M | -37 M | -33 M | 25 M | 35 M | 31 M | ||
| Non Current Prepaid Assets | 101000.0 | 101000.0 | 100900.0 | 47800.0 | ||||||
| Notes Payable | 105000.0 | 56500.0 | 57300.0 | 53900.0 | 54800.0 | 43600.0 | ||||
| Other Current Assets | 496000.0 | 1 M | 931900.0 | 814600.0 | 668700.0 | 451600.0 | 290500.0 | 142400.0 | ||
| Other Fixed Assets | 2 M | 2 M | 3 M | 3 M | 4 M | 4 M | 312700.0 | |||
| Other Non-current Assets | 454000.0 | 726000.0 | 495700.0 | |||||||
| Other Non-current Liabilities | 6 M | 5 M | 2 M | 2 M | ||||||
| Other Receivable | 1 M | 1 M | 300000.0 | |||||||
| Other Current Liabilities | 3 M | 2 M | 337200.0 | 66200.0 | 6 M | 4 M | 3 M | 2 M | ||
| Other Deferred Costs | 130000.0 | 218000.0 | 146400.0 | 234100.0 | ||||||
| Payables | 653000.0 | 2 M | 2 M | 3 M | 838300.0 | 2 M | 1 M | 1 M | 867300.0 | 936000.0 |
| Preferred Securities Of Subsidiary Trust | 500.0 | 500.0 | 500.0 | 500.0 | 500.0 | 500.0 | ||||
| Preferred Stock | 500.0 | 500.0 | 500.0 | 500.0 | 500.0 | 500.0 | ||||
| Prepaid Expenses | 2 M | 2 M | 802000.0 | 3 M | 875700.0 | 225100.0 | 228600.0 | 644800.0 | 456600.0 | 426800.0 |
| Retained Earnings | -408 M | -356 M | -327 M | -268 M | -220 M | -202 M | -181 M | -157 M | -142 M | -132 M |
| Short Term Debt | 105000.0 | 56500.0 | 57300.0 | 53900.0 | 54800.0 | 43600.0 | ||||
| Total Assets | 84 M | 124 M | 21 M | 75 M | 108 M | 6 M | 14 M | 11 M | 4 M | 989800.0 |
| Total Current Assets | 82 M | 121 M | 18 M | 71 M | 104 M | 2 M | 14 M | 11 M | 3 M | 855300.0 |
| Total Current Liabilities | 13 M | 5 M | 5 M | 6 M | 4 M | 28 M | 3 M | 1 M | 1 M | 2 M |
| Total Equity | 70 M | 114 M | 12 M | 65 M | 92 M | 500.0 | 500.0 | 7 M | 615800.0 | -3 M |
| Total Liabilities | 14 M | 9 M | 9 M | 10 M | 16 M | 12 M | 7 M | 4 M | 3 M | 4 M |
| Total Non-current Assets | 2 M | 3 M | 3 M | 4 M | 4 M | 4 M | 360500.0 | 255200.0 | 334300.0 | 134500.0 |
| Total Non-current Liabilities | 1 M | 4 M | 4 M | 4 M | 12 M | 9 M | 4 M | 3 M | 2 M | 2 M |
| Total Equity Gross Minority | 70 M | 114 M | 12 M | 65 M | 92 M | -6 M | 7 M | 7 M | 612300.0 | -3 M |
| Total Equity Gross Minority Interest | 70 M | 114 M | 12 M | 65 M | 92 M | -6 M | 7 M | 7 M | 612300.0 | -3 M |
| Total Liabilities And Total Equity Gross Minority Interest | 84 M | 124 M | 21 M | 75 M | 108 M | 6 M | 14 M | 11 M | 4 M | 989800.0 |
| Total Non Current Liabilities Net Minority Interes | 1 M | 4 M | 4 M | 4 M | 12 M | 9 M | 4 M | 3 M | 2 M | 2 M |
| Treasury Stock | -4 M | -4 M | -4 M | -4 M | -4 M | -4 M | -4 M | -4 M | -4 M | -4 M |
| Unearned Income | 321800.0 | 294900.0 | 47800.0 | 47800.0 | 47800.0 | 47800.0 | 46900.0 | |||
| Working Capital | 69 M | 116 M | 13 M | 65 M | 100 M | -26 M | 11 M | 10 M | 2 M | -939400.0 |
| Debtc | 561000.0 | 550000.0 | 591000.0 | 433300.0 | 367800.0 | 373200.0 | 60300.0 | 56500.0 | 57200.0 | 44700.0 |
Call: 1-877-778-8358 
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.
I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.
I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...
MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.
I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.